DS Healthcare files its second patent

Last week, DS Healthcare Group filed its second patent (first one was filed in October 2013) related to a new proprietary topical hair loss treatment.  From the news release regarding this development:

This new patent addresses the composition and methods of a new compound described as a calcium-activated potassium channel opening agent for topical treatment of hair loss.”

According to the company’s CEO Daniel Khesin, this patent-pending molecule will produce better hair regrowth results than topical minoxidil.

The company’s 1 year stock price movement chart:

Leave a Reply

Your email address will not be published. Required fields are marked *